Cath Lab Digest
The COVID-19 pandemic is creating a huge burden on global healthcare systems. The cardiovascular community, along with other specialties, is facing unprecedented pressure.
The first quarter of 2020 has been less than stellar, to say the least. The COVID-19 pandemic has completely turned the lives of healthcare workers upside down.
Coronary angiography and cardiac catheterization have become the gold standard for the diagnosis and management of coronary artery disease. Acute ischemic stroke during or after cardiac catheterization or percutaneous cardiac intervention (PCI) is a rare but catastrophic complication with significant morbidity and mortality.
Venous disease is a significant burden on the global medical system. It encompasses a variety of acute and chronic disease processes of both the deep and superficial vein system.
Most cardiovascular specialists realize that the majority of patients presenting with ischemic rest pain and non-healing wounds have already progressed to a multilevel occlusive arterial disease by the time they seek help.
The prevailing crisis with COVID-19 has unleashed a plethora of protocols, most of which are ridiculously complicated and take the reader through a labyrinth of rungs that recommend either unavailable resources or impractical pathways.
The Society for Cardiovascular Angiography and Interventions (SCAI) and the Canadian Association of Interventional Cardiology (CAIC) have announced the formation of the North American COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI).
Radial access continues to increase worldwide across multiple medical specialties due to its superior safety profile and presently accounts for approximately 40% of all cardiac catheterizations performed in the United States.
Current estimates suggest that peripheral arterial disease (PAD) may already affect up to 200 million people worldwide and approximately 8.5 million people in United States alone.
Percutaneous coronary intervention (PCI) of chronic coronary total occlusion (CTO) has been considered the final frontier in percutaneous intervention.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!